Medicare Rx Formularies May Omit Lexapro Or Celexa, CMS Says
This article was originally published in The Pink Sheet Daily
Executive Summary
Both antidepressants are not needed on Part D drug formularies “since escitalopram is the component of citalopram that is responsible for the antidepressant effects,” CMS says. Iressa and Cerebyx may also be left off formularies despite the requirement that “all or substantially all” drugs in their categories be included.
You may also be interested in...
Eisai's Rufinamide Estimated User Fee Deadline Is July 2006
The company submitted its NDA for the anti-epileptic on Sept. 9 for the orphan indication of adjunctive therapy for Lennox-Gastaut syndrome and for adjunctive therapy for partial-onset seizures.
Eisai's Rufinamide Estimated User Fee Deadline Is July 2006
The company submitted its NDA for the anti-epileptic on Sept. 9 for the orphan indication of adjunctive therapy for Lennox-Gastaut syndrome and for adjunctive therapy for partial-onset seizures.
Medicare Drug Plans Can Update Formularies Until Mid-September
Two-week window allows Part D plans to enhance or modify previously submitted formularies prior to the beginning of marketing activities.